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ABSTRACT
A high performance liquid chromatographic (HPLC) method equipped with a photodiode array detector was evaluated for the residual determination of 13 veterinary drugs, including clopidol, sulfadiazine, sulfathiazole, carbadox, sulfamerazine, ormethoprim, sulfamethazine, furazolidone, sulfamonomethoxine, sulfamethoxazole, ethopabate, sulfaquinoxaline, and sulfadimethoxine in chicken and swine
muscles. Test samples were extracted with acetonitrile and filtered. The filtrate was partitioned with acetonitrile-saturated n-hexane for
removing the interference. After evaporation to dryness, the residue was passed through a Sep-Pak C18 cartridge for sample cleanup prior
to HPLC analysis. Veterinary drugs were determined by HPLC equipped with a photodiode array detector using a Luna 5 µ C18 (2) 25 cm
× 4.6 mm i.d., 5 µm) analytical column and a gradient elution of acetonitrile and 0.05M sodium dihydrogen phosphate. The average recoveries of 13 veterinary drugs from chicken and swine muscles at the levels of 0.1, 0.2 and 0.4 ppm were in the range of 71.9 96.9% and
71.1~99.6%, respectively, with coefficients of variation less than 8%. The detection limits were 0.04 ppm for sulfathiazole and 0.02 ppm
for other 12 drugs.
Twenty-five samples each of chicken and swine muscles collected from local markets in Taipei were investigated for veterinary drug
residues. One chicken muscle sample was found to contain 1.23 ppm sulfaquinoxaline, the level of which exceeded the regulated tolerance.
Key words: veterinary drug, multiresidue, photodiode array detector, high performance liquid chromatography

INTRODUCTION
The purpose of using veterinary drugs is to prevent animals from getting disease, enhance feed efficiency, promote
animal growth, and improve productivity. The Council of
Agriculture of the Republic of China announced the “Rules
of Use of Feeds Additives Announcement”(1) on October
1982, in which 64 feed additives were approved. The residue
of veterinary drugs in food has received great attention in
recent years because of concerns over the request in food
safety by consumers. The improper use of veterinary drugs
(such as over-dose or not obeying the off-drug regulation)
could lead to drug residue in animal products. A detrimental
effect on human health could occur when people consume
those products containing veterinary drug residues. To solve
the problems of veterinary drug residue in animal products,
related authorities should take extra efforts in monitoring veterinary drug usage and enforcing inspection of commercial
products.
To prevent the abuse of veterinary drugs, the ROC
Department of Health announced the “Tolerances for
Residues of Animal Drugs”(2) in April 1987, in which the tolerance levels of 19 veterinary drugs in animal products were
declared. The analytical methods for most of these drugs are
established and some are still being determined. However,
the established methods are capable of analyzing only one or
* Author for correspondence. Tel: 02-26531258;
Fax: 02-26531256; E-mail:kaoamy@nlfd.gov.tw

a few drugs at one time. To improve the inspection efficiency,
it is necessary to establish a method, which allows multiple
drugs to be analyzed simultaneously. In compliance with the
“Tolerances for Residues of Animal Drugs”, 13 veterinary
drugs with similar chemical properties, including 8 sulfadrugs, clopidol, furazolidone, and carbadox (which tolerance levels are available), and ormethoprim and ethopabate
(which tolerance levels are not available) were selected in
this study. The purpose of this research was to develop an
analytical method for multiresidue determination of veterinary drugs in chicken and swine muscles.
According to the ROC “Tolerances for Residues of
Animal Drugs”, the tolerance levels for sulfadrugs in both
chicken and swine muscles are set at 0.1 ppm and for clopidol are 5 and 0.2 ppm in chicken and swine muscles, respectively. Residual furazolidone is not allowed in animal products. The tolerance level for carbadox in swine muscles is
0.03 ppm; however, the residual carbadox in animal products
is not permitted in the United States(3). There is no tolerance
level for ormethoprim and ethopabate according to the
“Tolerances for Residues of Animal Drugs”. In such cases,
the residual ormethoprim and ethopabate in animal products
are not allowable. In the US, the tolerance levels for the
above two drugs in chicken are set at 0.1 and 0.5 ppm, respectively.
A satisfactory analysis of veterinary drugs merely using
simple extraction and fixed wavelength detection is difficult
to achieve due to various veterinary drugs possessing differ-
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ent physical and chemical properties. Several approaches to
veterinary drug analysis have been reported, including using
a single solvent system to extract several veterinary drugs
with similar chemical properties from animal products followed by a single(4-9) or several cleanup steps(10, 11). The
mobile phase elution for HPLC analysis can be isocratic(4, 5,
7, 9), gradient(6, 12), or using several mobile phase systems,
and the detection can be a fixed wavelength(3) or multiple
wavelengths(5-10, 12). Because the photodiode array (PDA)
detector possesses the characteristics of wavelength selection
and spectrum identification, HPLC equipped with PDA was
therefore used as a tool to analyze 13 residual veterinary
drugs in chicken and swine muscles in this study.

clopidol (CLP), and furazolidone (FZD) were supplied by the
Bureau of Standards, Metrology and Inspection, Ministry of
Economic Affairs, ROC. Ormethoprim (OMP) and ethopabate (ETB) were obtained from the National Institute for
Animal Health, Council of Agriculture, ROC. Sulfadiazine
(SDZ), sulfamerazine (SMR), sulfamethazine (SMT), sulfamethoxazole (SMXZ), sulfaquinoxaline (SQX), sulfadimethoxine (SDMX), and carbadox (CDX) were purchased from the Sigma Chemical Co. (St. Louis, Missouri,
USA).
(II) Solvents and Other Reagents
LC grade acetonitrile was purchased from Lab-Scan Co.
(Dublin, Irene) and methanol was obtained from BDH
(Poole, England). GR grade sodium dihydrogen phosphate,
disodium hydrogen phosphate, and phosphoric acid (reagent
grade) were purchased from Merck (Darmstadt, Germany).

MATERIALS AND METHODS
I. Materials
Test samples, including 25 chicken (breast) and 25
swine muscle (loin) samples, were purchased from local markets in April 1999.

(III) Solid Phase Extraction Cartridge

II. Reagents

The Sep-Pak C18 cartridge (500 mg) was obtained from
Waters Co. (Milford, Massachusetts, USA).

(I) Standards

III. Equipment

Sulfathiazole (STZ), sulfamonomethoxine (SMMX),

Sulfadiazine

Sulfamethazine

Sulfaquinoxaline

Carbadox

Sulfathiazole

Sulfamerazine

Sulfamonomethoxine

Sulfamethoxazole

Sulfadimethoxine

Clopidol

Furazolidone

Figure 1. Chemical structures of 13 veterinary drugs.

1. ACE homogenizer: made by Nihonseiki Co. (Tokyo,

Ormethoprim

Ethopabate
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Japan).
2. pH meter: made by Metrohm Co. (Herisan,
Switzerland).
3. Rotary evaporator: made by Buchi Co. (Flawil,
Switzerland).
4. High performance liquid chromatograph: Shimadzu
LC-10AT equipped with a CBM-10A interface controller and
an SPD-M6A photodiode array detector.
IV. Preparation of 0.05M Sodium Dihydrogen Phosphate
Solution

same concentration bottle was then washed twice with 5 mL
of methanol and the resulting solution was passed through the
same cartridge. The eluate was collected and evaporated to
dryness at 40˚C using a rotary evaporator. The dry matter was
reconstituted with 1 mL of acetonitrile/water (3/7, v/v) solution. After spiking 0.5 mL of acetonitrile-saturated n-hexane,
the resulting solution was thoroughly mixed and then centrifuged at 3000 rpm for 5 min. The acetonitrile layer was
collected and filtered through a membrane prior to HPLC
analysis.
(III) HPLC Analysis

A solution of 0.05M sodium dihydrogen phosphate was
prepared and adjusted to pH 5.10 with 0.05M disodium
hydrogen phosphate.

1. Analytical conditions

VI. Analytical Methods

(1) Analytical column: Luna 5 µ C18 (2) column (25 cm × 4.6
mm i.d., 5µ), made by Phenomenex Co. (Torrance, CA,
USA).
(2) Mobile phase: (A) acetonitrile, (B) 0.05 M sodium dihydrogen phosphate. A following gradient elution was performed:
Time (min)
Flow rate (mL/min)
%A
%B
0
1.00
10
90
5
1.00
15
85
20
1.00
15
85
35
1.00
30
70
45
1.00
10
90
60
1.00
10
90
(It took 65 min to make one run, 45 min for analysis and
20 min for equilibrium.)
(3) Detection wavelength: 200~400 nm.
(4) Wavelength resolution: 1 nm.
(5) Integration time: 0.64 sec.
(6) Injection volume: 20 µL.

(I) Extraction

2. Standard curves

Test samples of chicken and swine muscles were
homogenized. The homogenate (5 g) and 50 mL of acetonitrile were then added into a mixer and mixed for 3 min. After
filtration, the residue was mixed with another 50 mL of acetonitrile. The mixing and filtration procedures were repeated.
The combined filtrate was transferred into a separation funnel
containing 30 mL of acetonitrile-saturated n-hexane and
shaken for 5 min. The acetonitrile layer was collected into a
concentration bottle and evaporated to dryness at 40˚C using
a rotary evaporator.

Five concentrations (0.2, 0.5, 1.0, 1.5, and 2.0 of
µg/mL) of mixed standard were prepared as described and 20
µL of each was injected. Standard curves were plotted
according to the peak areas versus concentrations.

V. Preparation of Standard Solution
(I) Standard Stock Solution
CDX (50 mg), and FZD, OMP, ETB, SDZ, STZ, SMR,
SMT, SMMX, SMXZ, SQX, and SDMX (100 mg of each)
were separately weighed into a 100-mL volumetric flask and
acetonitrile was added to the volume. CLP (100 mg) was
accurately weighed and dissolved in 100 mL of acetonitrile/water (1/1, v/v) solution.
(II) Standard Mix Solution
The above stock solutions were diluted with acetonitrile/0.05 M sodium dihydrogen phosphate (3/7, v/v) to a
series of concentrations ranging from 0.2 to 2.0 µg/mL.

(II) Sample Cleanup Using a Sep-Pak C18 Cartridge
The above dry residue was reconstituted with 20 mL of
0.05 M sodium dihydrogen phosphate and applied onto a
Sep-Pak C18 cartridge, which was pre-conditioned with 10
mL of methanol and 10 mL of 0.05 M sodium dihydrogen
phosphate. The concentration bottle was washed twice with 5
mL of sodium dihydrogen phosphate, which was then applied
onto the same cartridge. The eluate was disregarded. The

3. Quantification
Sample and standard solutions, 20 µL of each, were
individually injected to the HPLC instrument. Peak identification was made by comparing the retention times and spectra of samples with those of standards. The following formula was used to calculate the amounts of veterinary drugs in
test samples:
Amount of drug (ppm) = C x V/W
Where C is the drug concentration (µg/mL) calculated
by standard curve, V is the volume of sample solution (mL),
and W is the weight of sample (g).
VII. Recovery Test
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Recovery test was performed in triplicate by spiking
standards at 3 levels (0.1, 0.2, and 0.4 ppm) into homogenate.
The spiked samples and blank sample without standard were
then analyzed by HPLC. Recovery was calculated by comparing the analyzed concentrations with spiked concentrations.

analysis because the matrix interference at 308 nm was minimal. The absorbance intensity of OMP was decreased by
increasing the wavelength detection. To minimize the matrix
interference as well as maintain the absorbance intensity, the
wavelength at 230 nm was selected for OMP detection.
(II) Mobile Phase Selection

RESULTS AND DISCUSSION
I. Study on the HPLC Conditions
(I) The Optimal Wavelength of Detection
HPLC with photodiode array (PDA) detection has been
used for multiresidue analysis of veterinary drug in many
cases. In this study, a PDA detector was therefore used as a
tool to optimize the wavelength for the detection of the 13
veterinary drugs. The UV spectra ranged at 200~400 nm for
13 veterinary drugs are shown in Figure 2 and 3. As can be
seen, the maximum UV absorption of 8 sulfadrugs, CLP and
ETB are at 250 nm; while the maximum UV absorption of
other veterinary drugs are at 270 nm. Therefore, UV at 270
nm was used for the detection of most drugs in this study. The
optimum detection wavelengths selected for 13 veterinary
drugs analysis in this study are listed in Table 1. The optimum wavelengths for CDX and FZD detection were 308 and
368 nm, respectively. UV at 308 nm was selected for STZ
26.7

SDZ

26.2

A mobile phase with gradient elution has been widely
used for multiresidual analysis of veterinary drugs. In this
study, a mobile phase consisted of acetonitrile and sodium
dihydrogen phosphate was selected according to Horie et
al.(5) and Ishii et al.(6). In our preliminary study, we found
that the mixing ratio of the above two phases could significantly affect the analysis of some veterinary drugs. The CLP
peak was split into double peaks when a mobile phase containing more than 20% acetonitrile was used. When a mobile
phase containing more than 40% acetonitrile was used, the
OMP peak split into 2 peaks. A similar phenomenon was
observed by Keuo et al.(13). Therefore, to analyze CLP and
OMP, a acetonitrile concentration higher than 20% and 40%,
respectively, should be avoided. In addition, the resolution of
the peaks of veterinary drugs was affected by the pH of sodium dihydrogen phosphate solution. The effect of pH, ranging
from 3 to 6 adjusted by 1% phosphoric acid or 0.05M disodium hydrogen phosphate, on the retention times of 13 veterinary drugs is shown in Figure 4. The retention times of the
2.1

STZ

10.9

SMR

mAbs

mAbs

Abs

mAbs

0

0

0

0

200

300

400 200

Wavelength (nm)
1.2

SMMX

300

400 200

Wavelength (nm)
22.7

SMXZ

37.3

mAbs

mAbs

0

0

0

300

400 200

Wavelength (nm)

300

400 200

Wavelength (nm)

Abs

200

300

SQX

Figure 2. UV-absorption spectra of 8 sulfadrugs by photodiode array detector.

300

400

Wavelength (nm)
11.6

SDMX
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0
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4.2

30.0

CLP

Abs

mAbs

0

0

200

300

400

CDX

200

Wavelength (nm)
30.5

OMP

Abs
0

200

300

400

Wavelength (nm)

300

400

Wavelength (nm)

10.8

23.2

FZD

mAbs
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0

0

200

300

400

ETB

200

Wavelength (nm)

300

400

Wavelength (nm)

Figure 3. UV-absorption spectra of 5 veterinary drugs by photodiode array detector.

Table 1. Optimum detection wavelength of each veterinary drug analyzed by high performance liquid chromatography
Drug
λmax (nm)
270
CLPa
SDZ
270
STZ
308
CDX
308
SMR
270
OMP
230
SMT
270
FZD
368
SMMX
270
SMXZ
270
ETB
270
SQX
270
SDMX
270
aCLP: clopidol; SDZ: sulfadiazine; STZ: sulfathiazole; CDX: carbadox; SMR: sulfamerazine; OMP: ormethoprim; SMT: sulfamethazine;
FZD: furazolidone; SMMX: sulfamonomethoxine; SMXZ: sulfamethoxazole; ETB: ethopabate; SQX: sulfaquinoxaline; SDMX: sulfadimethoxine.

50

Figure 4. Effect of pH value in 0.05M sodium dihydrogen phosphate
solution on the retention time of HPLC for each veterinay drug.

analyte were not affected by the mobile phase at pH lower
than 4.5. However, under such conditions, the peak of SQX
overlapped with the SDMX peak. Separation of these two
peaks was achievable by increasing the pH of mobile phase
higher than 5.0. This is due to a dissociation constant difference between SQX (pKa=5.5) and SDMX (pKa=5.9). Using

a mobile phase with higher pH value was able to resolve the
peaks of SQX and SDMX; however, at pH 5.5, an overlapping between ETB and SQX, FZD and SMMX, and OMP
and SMT could occur. To optimize the resolution between
SQX and SDMX, a mobile phase containing 0.05M sodium
dihydrogen phosphate adjusted to pH 5.1 was thus used in

45
CLP
SDZ
STZ
CDX
SMR
OMP
SMT
FZD
SMMX
SMXZ
ETB
SQX
SDMX

Retention time (min)

40
35
30
25
20
15
10
5
0
3

3.5

4

4.5

5

5.5

6

pH value
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this study. The HPLC chromatograms of 13 veterinary drugs
by using a gradient elution of acetonitrile and 0.05M sodium
dihydrogen phosphate (pH 5.1), a C18 analytical column, and
a PDA detector, are shown in Figure 5. As can be seen, a satisfactory resolution for all analyte was obtained as using the
HPLC conditions developed in this study.

are also not applicable because they are difficult to evaporate
and can easily to block the cleanup cartridge. Acetonitrile
was found to be the best solvent for sample extraction
because it is easy to evaporate and the lipid/oil interference
could readily be removed from the extract solution by introducing n-hexane.

II. Sample Preparation

(II) Cleanup Conditions

(I) Solvent Extraction

In the preliminary study, a de-fat acetonitrile extract
without sample cleanup was analyzed by HPLC. Results
showed that many co-extracts appeared on the chromatogram
and interfered with the quantification of CLP, which was less
retained on the column and co-eluted with other interference.
To obtain a better result, a cleanup treatment is therefore
required.
It has been reported by Hori(10) that sulfadrugs can be
separated from other veterinary drugs using an aluminum
oxide cartridge. Based on the cleanup treatment reported by
Hori, in this study, veterinary drug standards were eluted
from aluminum oxide cartridge with 85% methanol and
methanol/acetic acid/water (30: 0.4: 70) followed by HPLC
analysis. Results showed that separation of sulfadrugs from
other spiked standards was not achievable. The recoveries of
SMT, SQX, and SDMX were even less than 20%. A satisfactory result was not achieved after testing other cartridges and
eluting conditions. Therefore, to search for a substitute
cleanup method is necessary.
A cleanup method for analysis of 10 sulfadrugs using a
C18 cartridge has been proposed by Horie et al.(5). In this
study, the acetonitrile extract was dissolved in 0.05M sodium
dihydrogen phosphate solution, loaded onto a C18 cartridge,
eluted with methanol, and analyzed by HPLC. It was found
that not only the interference peaks were significantly

Acetonitrile(10, 12), methanol(8), methanol/metaphosphoric acid solution(5), or acetonitrile/metaphosphoric acid
solution are widely used as extraction solvents for multiresidue analysis of veterinary drugs in animal products.
After extraction, a cleanup procedure using solid phase
extraction (aluminum oxide(8) or C18(5) cartridge) or liquidliquid partition(8) (methylene chloride) is then carried out.
Our preliminary study showed that methanol extract solution
readily foamed, suddenly boiled, and took time to concentrate when evaporated under vacuum. Methanol/metaphosphoric acid and acetonitrile/metaphosphoric acid solutions
mAbs
10 Chl 230nm
5
0
10

Ch2 270nm

5
0
10 Ch3 308nm
5
0
10 Ch4 368nm
5
0
0

10

20
30
Retention time (min)

40

Figure 5. HPLC chromatograms of 13 veterinary drugs by photodiode
array detector. HPLC conditions were described on text. Peaks: 1,
clopidol; 2, sulfadiazine; 3, sulfathiazole; 4, carbadox; 5, sulfamerazine; 6, ormethoprim; 7, sulfamethazine; 8, furazolidone; 9, sulfamonomethoxine; 10, sulfamethoxazole; 11, ethopabate; 12, sulfaquinoxaline; 13, sulfadimethoxine.

Table 2. Comparison of three kinds of C18 cartridges on the recovery
of each veterinary drug
Recovery (%)*
Drug
Sep-Pak C18
Sep-Pak C18
Adsorbex RP-18
(360 mg)
(500 mg)**
(400 mg)
N.D.**** c
CLP
54.2 ± 0.69b*** 87.7 ± 3.55a
SDZ
45.2 ± 1.97b
76.2 ± 3.96a
N.D. c
b
a
STZ
71.0 ± 4.76
84.5 ± 6.23
N.D. c
a
a
CDX
88.9 ± 4.17
83.4 ± 2.71
12.6 ± 3.72c
SMR
79.5 ± 6.04a
82.8 ± 6.50a
2.2 ± 3.15c
a
a
OMP
89.8 ± 4.51
96.5 ± 0.58
14.1 ± 6.63c
SMT
87.2 ± 5.80a
84.6 ± 4.70a
N.D. c
FZD
87.4 ± 4.51a
94.5 ± 3.34a
N.D. c
a
a
SMMX
89.8 ± 4.13
88.0 ± 4.25
N.D. c
SMXZ
85.1 ± 7.68a
84.6 ± 3.68a
N.D. c
ETB
92.9 ± 5.87a
97.0 ± 1.85a
61.6 ± 14.80b
SQX
70.6 ± 6.86ab
76.0 ± 1.92a
46.6 ± 12.52bc
SDMX
79.4 ± 8.26b
82.3 ± 0.71a
35.4 ± 13.44c
* Mean ± S.D. (n=2), Chicken muscle was spiked with 0.2 ppm of each
drug.
** Sorbent weight.
*** Means within a row followed by the same letter do not differ at the
5 % level by Duncan’s multiple range test.
**** Not detected.
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Sample
Extracted with 50 mL of CH3CN for 3 min and filtered
Repeated once
Filtrate
Partitioned with 50 mL of n-hexane saturated with CH3CN for 5 min

Table 3. Linear relationship of peak area versus concentration of each
veterinary drug by high performance liquid chromatography

CH3CN layer
Evaporated to dryness
Residue
Dissolved with 20 mL of 0.05M NaH2PO4
Sep-Pak C18 cartridge (500 mg)

n-Hexane layer
(discarded)

Drug
CLP
SDZ
STZ
CDX
SMR
OMP
SMT
FZD
SMMX
SMXZ
ETB
SQX
SDMX

Washed with 10 mL of 0.05M NaH2PO4
Eluted with 10 mL of CH3OH
Eluate
Evaporated to dryness
Residue
Dissolved with 1 mL of CH3CN/H2O (3/7, v/v)
Added with 0.5 mL of n-hexane saturated with
CH3CN and mixed
Centrifuged at 3000 rpm for 5 min
CH3CN/H2O layer

n-Hexane layer
(discarded)

HPLC-analysis
Figure 6. Analytical procedure for multiple residue of veterinary drugs
in chicken and swine muscles.
450000
400000
350000
CLP
SDZ
STZ
CDX
SMR
OMP
SMT
FZD
SMMX
SMXZ
ETB
SQX
SDMX

Peak area

300000
250000
200000
150000
100000
50000
0
0

0.5

1

1.5

2

2.5

recover the veterinary drugs is not dependent on packing size
but rather on the material size and shape, packing density,
carbon content of packing material, and end capping treatment(5). Based on the above study, the best cartridge for sample cleanup was found to be Sep-Pak C18 (500 mg).
To have more sulfadrugs retained in the cartridge, the

3

Concentration (µg/mL)
Figure 7. Standard curves of veterinary drugs with HPLC analyses.

reduced, but also the CLP peak clearly appeared on the chromatogram. Furthermore, 3 kinds of commercially available
C18 cartridges were compared in the recovery of veterinary
drugs after cleanup treatment. Results are shown in Table 2.
A statistical study showed that the cartridge (Sep-Pak)
packed with smaller sized (360 mg) packing material gave a
lower recovery for polar compounds, such as CLP, SDZ, and
STZ, as compared to the same brand 500 mg-packed cartridge. The Sep-Pak brand cartridges, both 360 and 500 mgpacking, showed higher recovery than the Adsorbex RP-18
(400 mg) cartridge. This result suggests that the ability to

Slope
68737
88531
46851
158884
85142
121622
84525
83113
75568
75757
83763
85551
80760

Intercept
-1435.4
-883.11
-1286.5
-5164.8
-2442.4
-1874.7
-4988.7
-7364.9
-5115.9
-1645.3
-1125.5
-2153.7
-4080.7

r2
0.9999
0.9998
0.9999
0.9998
1.0000
0.9999
0.9998
0.9948
0.9996
0.9998
0.9999
0.9996
0.9999

Table 4. Recoveries of 13 veterinary drugs spiked into chicken muscle
Recovery (%)a
Drug
0.1 ppmb
0.2 ppm
0.4 ppm
CLP
85.9 (3.98)c
87.1 (4.67)
87.2 (2.62)
SDZ
71.9 (4.55)
75.1 (3.07)
74.2 (0.85)
STZ
86.5 (5.90)
84.4 (7.05)
84.3 (3.58)
CDX
77.2 (3.02)
82.4 (2.69)
87.0 (2.71)
SMR
90.7 (7.63)
88.1 (5.55)
90.1 (3.39)
OMP
90.9 (6.28)
96.1 (5.02)
92.5 (4.85)
SMT
90.4 (6.48)
84.1 (6.80)
87.6 (4.27)
FZD
87.8 (3.13)
88.4 (4.48)
90.6 (2.64)
SMMX
77.8 (7.59)
81.3 (1.99)
85.7 (1.12)
SMXZ
85.4 (3.59)
84.3 (4.03)
85.7 (2.00)
ETB
96.9 (4.90)
94.6 (3.51)
93.5 (2.03)
SQX
76.9 (6.62)
75.1 (4.51)
78.6 (1.97)
SDMX
82.7 (4.53)
81.2 (1.19)
82.1 (4.02)
a Average of triplicate.
b Spike level.
c Number in parentheses represents coefficient of variation (%).
Table 5. Recoveries of 13 veterinary drugs spiked into swine muscle
Recovery (%)a
Drug
b
0.1 ppm
0.2 ppm
0.4 ppm
86.9 (3.07)
85.4 (3.25)
CLP
84.2 (5.36)c
SDZ
71.1 (5.89)
73.6 (1.16)
72.3 (4.18)
STZ
88.4 (4.15)
84.0 (2.42)
86.2 (3.17)
CDX
75.6 (5.91)
81.5 (3.11)
86.5 (2.74)
SMR
95.6 (0.39)
88.9 (2.18)
93.1 (2.38)
OMP
96.7 (2.16)
96.4 (0.92)
94.0 (1.36)
SMT
82.2 (6.05)
80.3 (2.22)
88.5 (2.27)
FZD
99.6 (5.30)
91.0 (4.94)
93.3 (1.31)
SMMX
77.8 (3.71)
83.6 (1.20)
90.5 (2.16)
SMXZ
82.4 (3.47)
84.4 (2.61)
88.5 (1.68)
ETB
91.4 (2.06)
95.2 (4.60)
96.6 (1.08)
SQX
71.7 (7.79)
73.1 (3.18)
79.5 (6.30)
SDMX
78.4 (4.67)
80.3 (4.93)
84.5 (4.83)
a Average of triplicate.
b Spike level.
c Number in parentheses represents coefficient of variation (%).
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cartridge needs to be treated with 0.05 M sodium dihydrogen
phosphate to maintain a electron-neutral condition prior to
sample application, because the sulfadrugs are amphoteric
compounds with pKa in neutral or weak acid region. In addition, the eluate reconstituted with acetonitrile/water (3/7, v/v)
needs to be extracted with n-hexane to remove oil/lipid and
then centrifuged to obtain a clear solution prior to HPLC
analysis. The operation procedure for the analysis of multiple
residues of veterinary drugs is demonstrated in Figure 6.
III. Standard Curve and Recovery Test

The standard curves for the 13 veterinary drugs in the
range of 0.2~2.0 µg/mL are shown in Figure 7. The slope,
intercept, and linearity (r2) of each curve are listed in Table 3.
A satisfactory linearity with the r2 greater than 0.99 was
achieved.
A recovery test was performed in triplicate by spiking 0
(as blank), 0.1, 0.2, and 0.4 ppm of 13 veterinary drugs to 5 g
ground samples. Test results are demonstrated in Table 4 and
5 and their HPLC chromatograms are shown in Figure 8. The
average recoveries of 13 veterinary drugs in chicken and
swine muscles were in the range of 71.9~96.9% and
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Figure 8. HPLC chromatograms of 13 veterinary drugs spiked into samples at the 0.2 ppm level (A,C) and blank sample (B,D). (A,B) Chicken muscle, (C,D) swine muscle. HPLC analytical conditions and peak numbers are the same as Figure 5.
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71.1~99.6% with coefficient of variation ranging at
0.85~7.63% and 0.39~7.79%, respectively. Of the 13 veterinary drugs, SDZ and SQX showed the least recovery with
average recoveries of 73.0 and 76.8%, respectively. This
could be due to SDZ is a highly polar compound, which is
less retained in C18 cartridge; while SQX shows less soluble
in acetonitrile(13). Except for SDZ and SQX, the average
recoveries of other tested drugs were higher than 80%.
The detection limit for 13 veterinary drugs was also
studied. Results showed that the detection limits of the tested
drugs in both chicken and swine muscles were 0.02 ppm
except for STZ, which detection limit was 0.04 ppm. Figure
9 shows the HPLC chromatograms for detection limit of 13
veterinary drugs.
IV. Comparison of the Established Method in this Study and
in Published Research

mAbs

mAbs
10

Many methods for the multiple analysis of veterinary
drugs have been developed on the basis of the drug varieties.
In compliance with the “Tolerances for Residues of Animal
Drugs” announced by the Department of Health, ROC, 13
veterinary drugs were selected in this study for developing a
method of multiple residue analysis. A PDA detector, which
possesses wavelength selection and spectrum identification
characteristics, was used to detect the analyte eluted from
HPLC column. Acetonitrile was used as an extraction solvent
in this study in accordance with Murayama et al.(12) and
Hori(10). The extraction solution was extracted with n-hexane
for removing fat/lipid and then analyzed by HPLC without
passing through a cartridge for further cleanup according to
analytical method reported by Murayama et al.(12). This
method resulted in many interference peaks showing in the
front of HPLC chromatogram and peaks overlapping
between FZD and SMMX, and SQX and SDMX. Therefore,
it is not suitable for a quantification purpose. A cleanup
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Figure 9. HPLC chromatograms for detection limit of 13 veterinary drugs. (A) Chicken muscle, (B) swine muscle. HPLC analytical conditions and
peak numbers are the same as Figure 5.
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n-hexane for removing fat/lipid as well as other co-extracts,
and a Sep-Pak C18 cartridge for sample cleanup prior to
HPLC analysis. This method is simple compared to the documented methods, capable of resolving FZD and SQX from
SMMX and SDMX peaks, respectively, and can give more
than 80% recovery of most test drugs (except for SDZ and
SQX). The developed method in this study is recommended
as an analytical method for multiresidual determination of 13
veterinary drugs, as it shows better precision and suitability
as compared to methods in published reports.

method using aluminum oxide and Sep-Pak C18 cartridges
was introduced by Hori(10) to fractionate 11 veterinary drugs
into 3 portions followed by HPLC analysis. This method is
time-consuming and the fractionation of 13 studied veterinary drugs cannot be completed. Horie et al.(5) introduced an
HPLC method using methanol/metaphosphoric acid as an
extraction solvent and C18 cartridge for sample cleanup to
analyze 10 sulfadrugs. This method is easy to operate but
could result in blocking of the cleanup cartridge. The above
method was modified by Ishii et al.(6) for HPLC analysis of
21 veterinary drugs by using a liquid-liquid partition with
dichloromethane for sample cleanup. Using the modified
method could give a cleaner chromatogram but less recovery
caused by an emulsion during liquid-liquid partition. Using
the HPLC condition developed by Ishii et al.(6) was not capable of giving a base-line separation between the peaks of
FZD and SMMX, and SQX and SDMX. The method developed in this study used acetonitrile as an extraction solvent,
mAbs
15 Ch1 230nm

V. Investigation of Veterinary Drugs in Commercial Chicken
and Swine Muscles
Twenty-five samples each of chicken and swine muscles
(50 samples in total) were collected from the retail markets in
Taipei and analyzed using the developed method. No drug
residue was detected in swine muscle samples, but SQX
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Figure 10. HPLC chromatograms for chicken muscle sample with sulfaquinoxaline residue of 1.23 ppm (A), and UV-absorption spectra of the peak
from this sample (B) and sulfaquinoxaline standard (C). HPLC analytical conditions are the same as Figure 5.
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(1.23 ppm) was found in 1 out of 25 chicken samples. The
HPLC chromatogram of the detected sample is shown in
Figure 10(A). SQX was further identified and confirmed by
comparing the spectra of the sample and the standard (Figure
10 (B) and (C)). The similarity between these two peaks was
0.9986.
The regulated level for sulfadrugs in chicken and swine
muscles is no more than 0.1 ppm according to the “Tolerances for Residues of Animal Drugs”. One chicken sample
with a SQX residue higher than the regulated level suggests
that use of veterinary drugs, including usage, dosage, and offdrug regulation, is not strictly followed by some farmers. The
results of this investigation could be a reference for authorities to further monitor the residue of veterinary drugs in commercial animal products and reinforce the administration of
veterinary drug users.

CONCLUSIONS
A method using HPLC equipped with a PDA detector to
simultaneously analyze 13 veterinary drugs (including 8 sulfadrugs) in chicken and swine muscles was developed in this
study. This method is easy to operate and capable of removing most interference after cleanup with a Sep-Pak C18 cartridge. The average recoveries for most test drugs were
greater than 80% except for SDZ and SQX. The detection
limit was less than 0.04 ppm. PDA detector can be used to
further confirm the compounds of interest by comparing the
spectra of analyte with those of standards. The developed
method is suggested to be a routine method for multiresidue
analysis of veterinary drugs in animal products.
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以高效液相層析法建立雞肉及豬肉中
動物用藥之多重殘留檢驗方法
*

（收稿： July 13, 2000 ；接受： September 21, 2000）

摘

要

本研究利用光二極體列陣檢測器之高效液相層析法建立雞肉及豬肉中 13 種動物用藥，包括氯煊啶
（clopidol）、磺胺嘧啶（sulfadiazine）、磺胺 唑（sulfathiazole）、卡巴得（carbadox）、磺胺甲基嘧啶（sulfamerazine）、歐美德普（ormethoprim）、磺胺二甲基嘧啶（sulfamethazine）、富來頓（furazolidone）、磺胺一
甲氧嘧啶（sulfamonomethoxine）、磺胺噁唑（sulfamethoxazole）、衣索巴（ethopabate）、磺胺奎林（sulfaquinoxaline）及磺胺二甲氧嘧啶（sulfadimethoxine）等殘留量之檢驗方法。雞肉及豬肉檢體以乙 萃取，
經過濾、以乙 飽和之正己烷去除雜質及濃縮後，以 Sep-Pak C18 過濾層析匣淨化，最後利用高效液相層析
（25 cm × 4.6 mm i.d., 5 µm）
，並採用乙 與磷酸二氫鈉
儀分析定量。所使用之層析管柱為 Luna 5 µ C18（2）
溶液為梯度移動相溶液，以光二極體列陣檢測器偵測。檢體中添加 13 種動物用藥 0.1 、 0.2 及 0.4 ppm 時，其
回收率於雞肉及豬肉中分別為 71.9 ∼ 96.9% 及 71.1 ∼ 99.6% ，變異係數介於 0.85 ∼ 7.63% 及 0.39 ∼ 7.79% 之
間。本方法在此二檢體中之檢出限量除磺胺 唑為 0.04 ppm 外，其餘均為 0.02 ppm 。將此方法應用於市售
雞肉及豬肉之殘留量分析，結果於 50 件檢體中檢出 1 件雞肉殘留磺胺奎林 1.23 ppm 。
關鍵詞：動物用藥，多重殘留，光二極體列陣檢測器，高效液相層析

